NCR3
Natural cytotoxicity triggering receptor 3
Also known as: 1C7, CD337, LY117, NCTR3_HUMAN, NKp30
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14931
- Gene
- NCR3
- Ensembl
- ENSG00000204475
- Chromosome
- 6
- Canonical length
- 201 aa
- Protein class
- CD markers, Predicted membrane proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a natural cytotoxicity receptor (NCR) that may aid NK cells in the lysis of tumor cells. The encoded protein interacts with CD3-zeta (CD247), a T-cell receptor. A single nucleotide polymorphism in the 5' untranslated region of this gene has been associated with mild malaria suceptibility. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
201 residues, UniProt reviewed canonical sequence.
>O14931|NCR3
1 MAWMLLLILI MVHPGSCALW VSQPPEIRTL EGSSAFLPCS FNASQGRLAI GSVTWFRDEV
61 VPGKEVRNGT PEFRGRLAPL ASSRFLHDHQ AELHIRDVRG HDASIYVCRV EVLGLGVGTG
121 NGTRLVVEKE HPQLGAGTVL LLRAGFYAVS FLSVAVGSTV YYQGKCLTWK GPRRQLPAVV
181 PAPLPPPCGS SAHLLPPVPG GLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NCR3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- spleen: 16 nTPM
- small intestine: 5.2 nTPM
- lymph node: 5.1 nTPM
- tonsil: 4.6 nTPM
- bone marrow: 3.8 nTPM
- appendix: 2.7 nTPM
Single-cell type
- nk-cells: 45 nCPM
- innate lymphoid cells: 17 nCPM
- t-cells: 13 nCPM
- b-cells: 11 nCPM
- medullary thymic epithelial cells: 2.4 nCPM
- kupffer cells: 2 nCPM
Immune cell
- MAIT T-cell: 275 nTPM
- gdT-cell: 99 nTPM
- NK-cell: 77 nTPM
- memory B-cell: 66 nTPM
- memory CD8 T-cell: 54 nTPM
- naive B-cell: 52 nTPM
Brain region
- cerebral cortex: 0.3 nTPM
- medulla oblongata: 0.2 nTPM
- pons: 0.2 nTPM
- thalamus: 0.2 nTPM
- white matter: 0.2 nTPM
- amygdala: 0.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NCR3.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 38 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Malaria, severe, susceptibility to
- Malaria, mild, susceptibility to
ReferencesPubMed · IEDB
Publications for NCR3 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome.
2016 · J Immunol · RCR 1.3 · 33 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.45
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.82
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell recognition
- immune response
- immune response-activating cell surface receptor signaling pathway
- inflammatory response
- natural killer cell activation
- NK T cell activation
- positive regulation of natural killer cell mediated cytotoxicity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NCR3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
- CD3Z
- BAG6
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NCR3 as an antibody target. Whether an autoantibody or antibody against NCR3 could matter depends on whether native NCR3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NCR3 is annotated at the cell surface, where native NCR3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NCR3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...